(Q41033255)

25 September 2017

title

Discovery of Influenza A virus neuraminidase inhibitors using support vector machine and Naïve Bayesian models (English)

1 reference

25 September 2017

0 references

support vector machine

1 reference

Wenwen Lian

1

1 reference

25 September 2017

Jiansong Fang

2

1 reference

25 September 2017

Chao Li

3

1 reference

25 September 2017

Xiaocong Pang

4

1 reference

25 September 2017

Ai-Lin Liu

5

1 reference

25 September 2017

Guan-Hua Du

6

1 reference

25 September 2017

publication date

21 December 2015

1 reference

25 September 2017

1 reference

25 September 2017

volume

20

1 reference

25 September 2017

issue

2

1 reference

25 September 2017

page(s)

439-451

1 reference

describes a project that uses

25 September 2017

support vector machine

1 reference

Seasonal influenza vaccines

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

The biology of influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Zanamivir: from drug design to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Influenza: the rational use of oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

A review of neuraminidase inhibitor susceptibility in influenza strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Edible bird's nest extract inhibits influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

The protective effect of 3-deoxysappanchalcone on in vitro influenza virus-induced apoptosis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Support vector machines for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Machine learning techniques and drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Bayesian Methods in Virtual Screening and Chemical Biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Random forest: a classification and regression tool for compound classification and QSAR modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Predicting inhibitors of acetylcholinesterase by regression and classification machine learning approaches with combinations of molecular descriptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Discriminating of ATP competitive Src kinase inhibitors and decoys using self-organizing map and support vector machine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Consensus models for CDK5 inhibitors in silico and their application to inhibitor discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Discovery of multitarget-directed ligands against Alzheimer's disease through systematic prediction of chemical-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Predicting dual-targeting anti-influenza agents using multi-models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Syntheses and neuraminidase inhibitory activity of multisubstituted cyclopentane amide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Carbocyclic influenza neuraminidase inhibitors possessing a C3-cyclic amine side chain: synthesis and inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Synthesis and evaluation of 1,4,5,6-tetrahydropyridazine derivatives as influenza neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Tamiphosphor monoesters as effective anti-influenza agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

A novel influenza virus neuraminidase inhibitor AV5027.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Synthesis and anti-influenza virus activity of 4-oxo- or thioxo-4,5-dihydrofuro[3,4-c]pyridin-3(1H)-ones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Serendipitous discovery of a potent influenza virus a neuraminidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Caffeic acid derivatives: a new type of influenza neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Further discovery of caffeic acid derivatives as novel influenza neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

An overview of statistical learning theory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Evaluation of virtual screening performance of support vector machines trained by sparsely distributed active compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

What is a support vector machine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Oversampling to overcome overfitting: exploring the relationship between data set composition, molecular descriptors, and predictive modeling methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

A novel method for mining highly imbalanced high-throughput screening data in PubChem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Insolubility classification with accurate prediction probabilities using a MetaClassifier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Combinatorial Consensus Scoring for Ligand-Based Virtual Fragment Screening: A Comparative Case Study for Serotonin 5-HT(3)A, Histamine H(1), and Histamine H(4) Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

The influence of 150-cavity binders on the dynamics of influenza A neuraminidases as revealed by molecular dynamics simulations and combined clustering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Selective Binding of Antiinfluenza Drugs and Their Analogues to ‘Open’ and ‘Closed’ Conformations of H5N1 Neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

A screening assay for neuraminidase inhibitors using neuraminidases N1 and N3 from a baculovirus expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11030-015-9641-Z

Editorial: mining for pharmacophores in phenotypic screens

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26689205

12 December 2020

inferred from PubMed ID database lookup

Oseltamivir-resistant seasonal A(H1N1) and A(H1N1)pdm09 influenza viruses from the 2007/2008 to 2012/2013 season in Nara Prefecture, Japan

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26689205

12 December 2020

inferred from PubMed ID database lookup

Overview of artificial neural networks

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26689205

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11030-015-9641-Z

1 reference

25 September 2017

1 reference